Robert M. Schelkun

Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: characterization of .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity

Christopher F. Bigge, Thomas C. Malone, Peter A. Boxer et al. · Journal of Medicinal Chemistry · 1995 · 58 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Preparation and reactivity of β-zinc and copper phosphonates

C. RETHERFORD, Tso-Sheng Chou, Robert M. Schelkun et al. · Tetrahedron Letters · 1990 · 47 citations · Full text

Natural Sciences, Chemistry, Inorganic Chemistry +6

Structure−Activity Relationship of <i>N</i>-(Phenylalkyl)cinnamides as Novel NR2B Subtype-Selective NMDA Receptor Antagonists

Amir P. Tamiz, Sui Xiong Cai, Zhang‐Lin Zhou et al. · Journal of Medicinal Chemistry · 1999 · 43 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Antagonists:  Benzimidazalone and Hydantoin as Phenol Replacements

Robert M. Schelkun, Po‐wai Yuen, Kevin A. Serpa et al. · Journal of Medicinal Chemistry · 2000 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: A novel antagonist at the 1a/2B NMDA receptor subtype

Amir P. Tamiz, Edward R. Whittemore, Robert M. Schelkun et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 16 citations

Medicine, Neuroscience, Pharmacology +14